N/A Completed N=64 Treatment

ReSTOR Natural +3.0D Study In Japan

Cataract

Source: ClinicalTrials.gov NCT00758576 ↗

Enrolled (actual)

Serious AEs

1.6%

Results posted

Dec 2010

Primary outcomePrimary: Uncorrected Intermediate Visual Acuity — 0.771; 0.861 Decimal Visual Acuity

Summary

The objective of this study is to evaluate safety and effectiveness of ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1 when implanted to replace the natural lens following cataract removal.

Outcome Measures

Outcome	Result	p-value
PRIMARY Uncorrected Intermediate Visual Acuity	0.771; 0.861	—
PRIMARY Uncorrected Distance Visual Acuity	1.122	—
PRIMARY Uncorrected Near Visual Acuity	1.082	—

Eligibility Criteria

Inclusion Criteria

Planned bilateral cataract removal by phacoemulsification
Potential postoperative best corrected visual acuity of 0.5 or over
1.5 Diopter (D) or less of astigmatism preoperatively, measured by keratometry

Exclusion Criteria

Poorly controlled glaucoma
Progressive diabetic retinopathy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00758576). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.